Sildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer. (Record no. 27798974)

MARC details
000 -LEADER
fixed length control field 01499 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517184840.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201909s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1029-2330
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1080/1061186X.2017.1405427
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Greish, Khaled
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190930
245 00 - TITLE STATEMENT
Title Sildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of drug targeting
Date of publication, distribution, etc. 08 2018
300 ## - PHYSICAL DESCRIPTION
Extent 610-615 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotics, Antineoplastic
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Models, Animal
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Delivery Systems
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mammary Neoplasms, Experimental
General subdivision pathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanoparticles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phosphodiesterase 5 Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sildenafil Citrate
General subdivision pharmacology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fateel, Maryam
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Abdelghany, Sara
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rachel, Nanitha
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Alimoradi, Houman
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bakhiet, Moiz
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Alsaie, Ahmed
773 0# - HOST ITEM ENTRY
Title Journal of drug targeting
Related parts vol. 26
-- no. 7
-- p. 610-615
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1080/1061186X.2017.1405427">https://doi.org/10.1080/1061186X.2017.1405427</a>
Public note Available from publisher's website

No items available.